Cargando…

Does Treatment of Hepatitis C Reduce Inhibitor Titers in Hemophilia A?

Detalles Bibliográficos
Autores principales:	Atay, Memiş Hilmi, Türkoğlu, Emine, Kelkitli, Engin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160695/ https://www.ncbi.nlm.nih.gov/pubmed/35393853 http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0085

Ejemplares similares

An Unusual Cause of Thigh Swelling: Extramedullary Myeloid Tumor
por: Atay, Memiş Hilmi, et al.
Publicado: (2014)

Hydroxyurea-induced Tooth Discoloration
por: Okuyucu, Muhammed, et al.
Publicado: (2020)

A Rare Case of Langerhans Cell Histiocytosis in the Hard Palate
por: Atay, Memiş Hilmi, et al.
Publicado: (2022)

A tuberculosis case mimicking lymphoma
por: Atay, Hilmi, et al.
Publicado: (2014)

Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
por: Ahn, Ji Hyun, et al.
Publicado: (2021)

Hepatitis C Genotypes in Hemophilia Patients in Iran
por: Bokharaei-Salim, F
Publicado: (2011)

Hepatitis C Genotypes in Hemophilia Patients in Iran
por: Hamidi-Fard, M
Publicado: (2011)

Mantle Cell Lymphoma Mimicking Rectal Carcinoma
por: Kelkitli, Engin, et al.
Publicado: (2014)

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
por: Saba, Hussain I, et al.
Publicado: (2011)

Quality of Life in Hemophilia Complicated by Inhibitors
por: Bastani, P, et al.
Publicado: (2012)

Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

Acquired Hemophilia
por: Özsoylu, Şinasi
Publicado: (2014)

Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy
por: Tsutsumi, Y, et al.
Publicado: (2009)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran
por: Karimi, Mehran, et al.
Publicado: (2016)

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
por: Tjønnfjord, Geir E, et al.
Publicado: (2007)

Hepatitis B virus vaccination of voluntary blood donors and immunization status assessment by Anti-Hepatitis B Surface (HBs) antibody titer
por: Singh, R. P., et al.
Publicado: (2013)

The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study
por: Güler, Nil, et al.
Publicado: (2014)

Correlation between Hepatitis B Surface Antigen Titers and HBV DNA Levels: What about the Parameters Affecting this Correlation?
por: Karagoz, Ergenekon, et al.
Publicado: (2014)

Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study
por: Halimeh, Susan, et al.
Publicado: (2013)

Conservative therapy for spinal epidural hematoma in a child with hemophilia A with high-titer VIII inhibitors
por: Wang, Guige, et al.
Publicado: (2021)

Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises
por: Demirci, Ufuk, et al.
Publicado: (2022)

HCV Genotypes of People with Hemophilia in Countries with High Seroprevalances
por: Mahlangu, J N, et al.
Publicado: (2011)

Prospective Evaluation of Non-Compliant Severe Hemophilia Patients
por: Uğur, Mehmet Can, et al.
Publicado: (2019)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Perioperative management of a hemophilia B infant with intracranial hemorrhage
por: Juneja, Sarika, et al.
Publicado: (2012)

Practices and challenges for hemophilia management under resource constraints in Thailand
por: Moonla, Chatphatai, et al.
Publicado: (2023)

Antibody titers and protection against a SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Spontaneous resolution of COVID-19-associated retinopathy diagnosed with raised antibody titer
por: Patnaik, Gazal, et al.
Publicado: (2021)

Second case of postpartum acquired hemophilia A in a Korean female
por: Lee, Kun Soo, et al.
Publicado: (2014)

Perioperative management of a patient with hemophilia A and crigler-najjar syndrome
por: Bhoi, Debesh, et al.
Publicado: (2013)

Prisoners Treated for Hepatitis C with Protease Inhibitor, New York, USA, 2012
por: Moorjani, Harish, et al.
Publicado: (2015)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Coronary Artery Bypass Surgery, Angioplasty and Long Term Anti-Platelet Treatment in a Type B Hemophilia Patient
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2009)

Sickle cell-β thalassemia with concomitant hemophilia A: a rare presentation
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Pregnancy exacerbates complications of acquired hemophilia in a patient with systemic lupus erythematosus
por: Sebastian, Agata, et al.
Publicado: (2015)

Severe Hematuria and Prevesical Hematoma after Open Ureterocystoneostomy: Sequel of Undiagnosed Hemophilia
por: Hisamatsu, Eiji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_056kc5mgacn8u8s3dnf2j4r7nq